Skip to main content
. 2026 Mar 9;153(10):769–785. doi: 10.1161/CIRCULATIONAHA.125.072393

Figure 4.

Figure 4.

Schematic of upstream triggers and downstream osteochondrogenic pathways in cardiovascular cells. Mechanisms believed to drive aortic and aortic valve calcification. Pathways shaded in blue are functionally related under the concept of inflammaging. Details are described in the text. As indicated, RUNX2 (runt-related transcription factor 2) appears to be central, leading the final common pathways to bone and cartilage tissue formation, which are not shown. Also not included are some inhibitory factors, such as fetuin and sclerostin. ABCC6 indicates ATP-binding cassette subfamily C member 6; AGE, advanced glycation end product; ALP, alkaline phosphatase; ANK, ankyrin; ATX, autotaxin; BMP, bone morphogenetic protein; c-WNT, canonical Wnt; CKD, chronic kidney disease; CPP, calciprotein particle; ECM, extracellular matrix; ENPP1, ectonucleotide pyrophosphatase/phosphodiesterase 1; FGF23, fibroblast growth factor 23; IL-1β, interleukin-1β; IL-6, interleukin-6; IFN, interferon; Lp(a), lipoprotein a; LRP6, low-density lipoprotein receptor-related protein 6; MGP, matrix Gla protein; miRNA, microRNA; nc-WNT, noncanonical Wnt; OPG, osteoprotegerin; OxLDL, oxidized low-density lipoprotein; p-OPN, phosphorylated osteopontin; PPi, inorganic pyrophosphate; PTH, parathyroid hormone; PTHr, parathyroid hormone receptor; RANK, receptor activator of nuclear factor-κΒ; RANKL, receptor activator of nuclear factor-κΒ ligand; ROS, reactive oxygen species; TERT, telomerase reverse transcriptase; TLR3, Toll-like receptor 3; and TNFα, tumor necrosis factor.